Arcoma

Arcoma Long-term Debt

Long-Term Debt of Arcoma (ARCOMA.ST) as of Oct 25, 2026.

Long-term Debt

0.00SEK

Last updated:

Long-Term Debt of Arcoma is 2025 0.00 SEK. Long-Term Debt of Arcoma was 2024 0.00 SEK. It decreases by % lower compared to the previous year.

The Arcoma Long-term Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Long-term Debt
Date
Long-term Debt
Jan 1, 2018
792,000.00 SEK
Jan 1, 2019
292,000.00 SEK
Jan 1, 2020
2.54 M SEK
Jan 1, 2021
1.81 M SEK
Jan 1, 2022
3.87 M SEK
Jan 1, 2023
1.93 M SEK
Jan 1, 2024
0.00 SEK
Jan 1, 2025
0.00 SEK
The Arcoma Long-term Debt history
YEARLong-term DebtYoY
0.00SEK—
0.00SEK-100.00%
1.93 MSEK-50.25%
3.87 MSEK+113.51%
1.81 MSEK-28.64%
2.54 MSEK+770.55%
292,000.00SEK-63.13%
792,000.00SEK-36.64%
1.25 MSEK-28.57%
1.75 MSEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Arcoma Stock analysis

What does Arcoma do? Arcoma AB generates revenue through the sale of its digital radiographic systems, which include complete systems like ceiling suspensions and floor-mounted units, as well as detectors and components such as overhead tube cranes and radiographic tables. The company markets its products under the IMIX brand, through private label distributors, and as original equipment manufacturer (OEM) solutions. Its primary customers are hospitals, clinics, imaging centers, and private practices seeking digital imaging technology with advanced mobile positioning systems. The Precision and Elite mobile imaging table series are key product offerings within its portfolio. The company's business model relies on direct sales of IMIX-branded systems to healthcare facilities, while also supplying components to private label distributors and OEM partners. These channels allow Arcoma to reach a broad range of healthcare providers across different segments. The firm's product range targets facilities requiring flexible, mobile imaging solutions for diagnostic procedures. Arcoma AB's revenue streams are derived from the sale of complete radiographic systems, system components, and mobile imaging tables, all designed for healthcare environments. The IMIX brand represents the company's direct-to-customer offering, while private label and OEM arrangements provide additional distribution pathways. The Precision and Elite series specifically cater to the needs of medical practices requiring mobile diagnostic equipment. Arcoma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Arcoma stock

On Eulerpool you can find the complete historical development of Long-Term Debt Arcoma since 2006 – with annual values, charts, and detailed analysis.

Long-term debt represents obligations due after one year. It is a key component of a company's capital structure and leverage.

Long-Term Debt's SEK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Long-Term Debt's Arcoma historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Arcoma

All Key Metrics — Arcoma